HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

VREX

Varex Imaging Corporation (NASDAQ)

Healthcare — Medical Devices

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. It operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products are used in a range of applications, including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses. The Industrial segment designs, develops, manufactures, sells, and services Linatron X-ray linear accelerators, non-intrusive cargo inspection systems, X-ray tubes, digital detectors, high voltage connectors, and coolers for use in security and inspection applications, such as baggage screening at airports, cargo screening at ports and borders, and nondestructive testing, irradiation, and inspection in various applications. It sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, Latin America, Europe, the Middle East, India, Africa, Asia, and Australia. The company was incorporated in 2016 and is headquartered in Salt Lake City, Utah.

None 5 analysts
$10.68
$-0.04 (-0.37%)
Target: $18.00 (68.5%)
Sign in to add VREX to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$463.19M
P/E Ratio (TTM)-
Forward P/E10.33
EPS (TTM)$-2.00
Dividend Yield-
Profit Margin-9.64%
Revenue Growth1.50%
ROE-15.68%
Debt/Equity78.06
Recommendation None
Analyst Target$18.00
Analysts5
Indexes NASDAQ

Technical Indicators

RSI (14)49.4
Beta0.90
SMA 20-
SMA 40-
52-Week High$14.57
52-Week Low$6.76
50-Day Avg$10.67
200-Day Avg$11.76
Avg Volume455.2K
Volume158.3K

Performance Analysis

NEUTRAL

VREX presents a mixed picture with both positive and negative indicators.

~ Trading at 50% of its 52-week range.
~ RSI at 49.4 is in neutral territory.
~ Modest revenue growth of 1.5% year-over-year.
- Operating at a loss with -9.6% margin.
~ Wall Street consensus is "none" from 5 analysts.
+ Average analyst target of $18.00 implies 68.5% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:37 UTC

Back to Screener Export Report